ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The majority of cases are in the CML‐blast phase (CML‐BP), where the progression from chronic to BP is thought to be secondary to the sequential acquisition of inv(16)(p13q22) on top of a pre‐existing BCR::ABL1 rearrangement [1, 25].